| Bioactivity | Anticancer agent 158 (compound 7c) is a potent anticancer agent. The IC50s for inhibiting HepG-2, MDA-MB-231, and HCT-116 cell lines are 7.93 μM, 9.28 μM, 13.28 μM, and 181.89 μM, respectively[1]. |
| Name | Anticancer agent 158 |
| Formula | C27H27N9OS2 |
| Molar Mass | 557.69 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Al-Humaidi J Y, et al. Synthesis, Biological Evaluation, and Molecular Docking of Novel Azolylhydrazonothiazoles as Potential Anticancer Agents[J]. ACS Omega, 2023.. . . |
Anticancer agent 158
CAS: F: C27H27N9OS2 W: 557.69
Anticancer agent 158 (compound 7c) is a potent anticancer agent. The IC50s for inhibiting HepG-2, MDA-MB-231, and HCT-11
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.